PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10447088-4	1999	A [3H]thymidine incorporation study showed that SS significantly and concentration-dependently inhibited HL60 and BALL-1 leukemia cell growth.	Tritium	3-5	somatostatin	Homo sapiens	48-50	
15680393-4	2005	Cell proliferation in response to SST treatment (0.04, 0.2, or 1 ng/ml) was performed by [3H]thymidine incorporation.	Tritium	90-92	somatostatin	Homo sapiens	34-37	
15680393-11	2005	SST-treated cells showed a significant reduction in [3H]thymidine incorporation in a dose-dependent manner.	Tritium	53-55	somatostatin	Homo sapiens	0-3	
10598791-3	1999	Total [3H]phosphoinositide (IPx) accumulation, a measure of phospholipase C (PLC) activity, induced by somatostatin (somatotropin release-inhibiting factor, SRIF) and cortistatin (CST) analogues was studied at human somatostatin receptor subtypes 1-5 (hsst1-5) recombinantly expressed in CCL39 (Chinese hamster lung fibroblast) cells.	Tritium	7-9	somatostatin	Homo sapiens	103-115	
2888257-4	1987	It was shown that SST (10(-7)-10(-5) M) significantly inhibited the [3H]-thymidine incorporation.	Tritium	69-71	somatostatin	Homo sapiens	18-21	
7905785-8	1994	Furthermore, SST and OCT inhibited VIP-induced [3H]thymidine incorporation, cyclic AMP formation, and tyrosine kinase activity with IC50 values < 10 nM.	Tritium	48-50	somatostatin	Homo sapiens	13-16	
1362264-4	1992	A significant (p < 0.02) inhibitory effect of somatostatin (1 nM to 10 microM) on 3H-thymidine DNA incorporation was observed in cultured chondrocytes from fetuses of all gestational ages studied (12-40 wk), with no significant differences among fetal ages.	Tritium	85-87	somatostatin	Homo sapiens	49-61	
6117356-2	1981	Local injection of somatostatin, i.e., without any measurable systemic effect, resulted in a 75% reduction of cell proliferation as measured by [3H]thymidine incorporation and ornithine decarboxylase activities.	Tritium	145-147	somatostatin	Homo sapiens	19-31	
3026563-4	1986	The binding of [3H]somatostatin in both the frontal cortex and cerebellar cortex demonstrated pharmacological specificity, since somatostatin-28, but not somatostatin-28(1-12) or Des AA1,2,4,5,12,13, D-Trp8-somatostatin, competed for the binding sites.	Tritium	16-18	somatostatin	Homo sapiens	129-144